HUP0202537A2 - Vakcinakészítmény és eljárás annak alkalmazására - Google Patents
Vakcinakészítmény és eljárás annak alkalmazásáraInfo
- Publication number
- HUP0202537A2 HUP0202537A2 HU0202537A HUP0202537A HUP0202537A2 HU P0202537 A2 HUP0202537 A2 HU P0202537A2 HU 0202537 A HU0202537 A HU 0202537A HU P0202537 A HUP0202537 A HU P0202537A HU P0202537 A2 HUP0202537 A2 HU P0202537A2
- Authority
- HU
- Hungary
- Prior art keywords
- subject
- same
- vaccine composition
- vaccine
- immunization
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 2
- 230000003053 immunization Effects 0.000 abstract 2
- 238000002649 immunization Methods 0.000 abstract 2
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Virology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Abstract
A találmány tárgya stabil, tömörített, préselt vagy keménytablettázott vakcinakészítmény, amely legalább egy liofilizáltantigenikus komponenst valamint oldódást elősegítő anyagot tartalmaz.Szintén a találmány tárgyát képezi eljárás egy alany betegség elleniimmunizálásának gyorsításra, amely szerint a tömörített, préselt vagykemény, tablettázott vakcinakészítményt először feloldjuk egycsomagolásban oldószerrel vakcinaoldatot állítanak elő és azeredményül kapott vakcinaoldatot beadják akkora mennyiségben, amelyhatásos az immunizálásra. Ó
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15051499P | 1999-08-24 | 1999-08-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0202537A2 true HUP0202537A2 (hu) | 2002-11-28 |
HUP0202537A3 HUP0202537A3 (en) | 2004-05-28 |
Family
ID=22534899
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0202537A HUP0202537A3 (en) | 1999-08-24 | 2000-08-21 | A vaccine composition and method of using the same |
Country Status (21)
Country | Link |
---|---|
US (1) | US6541001B1 (hu) |
EP (1) | EP1212045B1 (hu) |
JP (1) | JP5209160B2 (hu) |
CN (1) | CN100406004C (hu) |
AU (1) | AU779403B2 (hu) |
BR (1) | BRPI0014142B8 (hu) |
CA (1) | CA2382652A1 (hu) |
CY (1) | CY1118521T1 (hu) |
DK (1) | DK1212045T3 (hu) |
ES (1) | ES2605109T3 (hu) |
HK (1) | HK1047696A1 (hu) |
HU (1) | HUP0202537A3 (hu) |
IL (2) | IL148247A0 (hu) |
LT (1) | LT1212045T (hu) |
MX (1) | MXPA02001891A (hu) |
PL (1) | PL364983A1 (hu) |
PT (1) | PT1212045T (hu) |
RU (1) | RU2277905C2 (hu) |
TR (1) | TR200200477T2 (hu) |
WO (1) | WO2001013896A1 (hu) |
ZA (1) | ZA200201816B (hu) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6592869B2 (en) * | 1999-08-24 | 2003-07-15 | Teva Pharmaceutical Industries, Ltd. | Vaccine composition and method of using the same |
US7923023B2 (en) * | 2002-02-25 | 2011-04-12 | Astech International LLC | Method and composition for delivery of medicants to animals |
JP5291878B2 (ja) * | 2003-01-07 | 2013-09-18 | イエダ リサーチ アンド デベロップメント カンパニー リミテッド | 治療的免疫のためのコポリマー1を含む点眼ワクチン |
AU2004216559B2 (en) * | 2003-02-28 | 2010-05-27 | Alk-Abello A/S | Dosage form having a saccharide matrix |
US8012505B2 (en) | 2003-02-28 | 2011-09-06 | Alk-Abello A/S | Dosage form having a saccharide matrix |
US7858607B2 (en) * | 2003-03-14 | 2010-12-28 | Mamchur Stephen A | System for use by compounding pharmacists to produce hormone replacement medicine customized for each consumer |
US20050208083A1 (en) * | 2003-06-04 | 2005-09-22 | Nanobio Corporation | Compositions for inactivating pathogenic microorganisms, methods of making the compositons, and methods of use thereof |
WO2005021056A1 (en) * | 2003-08-21 | 2005-03-10 | Cns, Inc. | Effervescent delivery system |
JP5183068B2 (ja) * | 2003-12-22 | 2013-04-17 | フィンレイ,ウォーレン,エイチ | 大気噴出凍結乾燥法による粉末形成 |
US20050175630A1 (en) * | 2003-12-23 | 2005-08-11 | Eyal Raz | Immunogenic compositions and methods of use thereof |
JP2006143594A (ja) * | 2004-11-16 | 2006-06-08 | Shionogi & Co Ltd | 注射錠 |
ES2470340T3 (es) | 2005-12-28 | 2014-06-23 | Advanced Bionutrition Corporation | Vehículo de administración para bacterias probi�ticas que comprende una matriz seca de polisac�ridos, sac�ridos y polioles en forma vítrea |
EP1981547B1 (en) * | 2005-12-28 | 2015-09-30 | Alza Corporation | Stable therapeutic formulations |
DE102006054260A1 (de) * | 2006-02-28 | 2007-09-27 | Lohmann Animal Health Gmbh & Co. Kg | Wasser stabilisierende Zusammensetzung, Verfahren zu deren Herstellung und deren Verwendung |
JP4935761B2 (ja) * | 2008-06-02 | 2012-05-23 | 株式会社微生物化学研究所 | 家禽大腸菌症ワクチン |
DK2435554T3 (en) | 2009-05-26 | 2017-10-30 | Advanced Bionutrition Corp | STABLE DRY POWDER COMPOSITION WITH BIOLOGICALLY ACTIVE MICRO-ORGANISMS AND / OR BIOACTIVE MATERIALS AND PROCEDURES FOR ITS PREPARATION |
US9504750B2 (en) | 2010-01-28 | 2016-11-29 | Advanced Bionutrition Corporation | Stabilizing composition for biological materials |
CN102725393B (zh) | 2010-01-28 | 2015-12-02 | 先进生物营养公司 | 包含生物活性材料的干燥玻璃质组合物 |
TW201233803A (en) | 2010-12-02 | 2012-08-16 | Oncolytics Biotech Inc | Lyophilized viral formulations |
JP6034798B2 (ja) | 2010-12-02 | 2016-11-30 | オンコリティクス バイオテク,インコーポレーテッド | 液体ウイルス製剤 |
DK2741740T3 (en) * | 2011-08-12 | 2017-06-06 | Merial Inc | VACUUM-SUPPORTED CONSERVATION OF BIOLOGICAL PRODUCTS, IN PARTICULAR OF VACCINES |
MY178686A (en) * | 2012-03-23 | 2020-10-20 | Advanced Bionutrition Corp | Stabilizing composition for biological materials |
TWI745278B (zh) * | 2014-10-10 | 2021-11-11 | 以色列商艾畢克生物實驗有限公司 | 發泡性降低之疫苗組合物 |
PT3236881T (pt) | 2014-12-22 | 2021-05-14 | The Univ Of Georgia Research Foundation Inc | Sistema para vacinação de aves |
DK3328215T3 (da) | 2015-07-29 | 2021-09-13 | Advanced Bionutrition Corp | Stabilt tørre probiotiske sammensætninger til særlige kostanvendelser |
Family Cites Families (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB929377A (en) | 1961-02-09 | 1963-06-19 | Carl Peter Varnet | Foot and mouth disease implantation preparations |
US3317393A (en) | 1964-06-08 | 1967-05-02 | Robert M Chanock | Immunization by selective infection of the intestinal tract with an encapsulated live virus |
US3458621A (en) * | 1966-08-31 | 1969-07-29 | American Home Prod | Tablet dosage-form for the immunization of the intestinal tract with live virus preparations |
US3603030A (en) | 1969-08-29 | 1971-09-07 | Remco Ind Inc | Jumping toy |
FR2082760A5 (en) | 1970-03-26 | 1971-12-10 | France Etat | Aerosol immunisation appts - for freeze-dried vaccines |
DD106660A1 (hu) | 1972-04-10 | 1974-06-20 | ||
US3893280A (en) | 1972-06-21 | 1975-07-08 | Burns Biotec Lab Inc | Transfer packaging for biologicals |
DE2237783A1 (de) | 1972-08-01 | 1974-02-14 | Bayern Freistaat | Impfstoffzubereitung zur oralen pocken-impfung |
DD117250A1 (hu) | 1974-11-20 | 1976-01-05 | ||
BE853923A (fr) | 1977-04-25 | 1977-10-25 | Rit Rech Ind Therapeut | Nouveau vaccin vivant ameliore contre le pseudopeste aviaire et son procede de preparation |
US4235871A (en) | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
US4251509A (en) | 1980-01-31 | 1981-02-17 | Wisconsin Alumni Research Foundation | Dry particulate vaccine for oral administration |
US4458630A (en) | 1982-06-22 | 1984-07-10 | The United States Of America As Represented By The Secretary Of Agriculture | Disease control in avian species by embryonal vaccination |
HU188847B (en) * | 1983-02-22 | 1986-05-28 | Human Oltoanyagtermeloe Es Kutato Intezet,Hu | Process for producing liophylized combined vaccines |
JPS63264518A (ja) * | 1987-04-21 | 1988-11-01 | Wakamoto Pharmaceut Co Ltd | 発泡性錠剤の製法 |
IL86180A (en) | 1987-05-04 | 1992-08-18 | Merck & Co Inc | Stable lyophilized live herpes virus vaccine and such a vaccine combined with other virus vaccines |
US5710014A (en) | 1988-02-11 | 1998-01-20 | The United States Of America As Represented By The Department Of Health And Human Services | Cloned cDNA for human procathepsin l. |
US5472710A (en) | 1988-04-16 | 1995-12-05 | Schwarz Pharma Ag | Pharmaceutical preparation to be administered orally with controlled release of active substance and method for its manufacture |
IL89899A (en) | 1988-05-16 | 1992-12-01 | Reynolds Tobacco Co R | Smoking article with improved means for delivering flavorants |
US5350741A (en) | 1988-07-30 | 1994-09-27 | Kanji Takada | Enteric formulations of physiologically active peptides and proteins |
DK0495008T3 (da) | 1989-10-02 | 1997-10-13 | Univ Arkansas | Vaccinekonjugat til behandling af fuglesygdomme |
WO1991004750A1 (en) * | 1989-10-02 | 1991-04-18 | Embrex, Inc. | Method of treatment |
JP3412694B2 (ja) | 1989-10-02 | 2003-06-03 | シーマ・ラブス、インコーポレイテッド | 発泡性投与剤 |
DD289201A5 (de) | 1989-11-28 | 1991-04-25 | Fi Fuer Lungenkrankheiten Und Tuberkulose,De | Verfahren zur herstellung einer immunmodulierenden vakzine gegen viren |
DD289200A5 (de) | 1989-11-28 | 1991-04-25 | Forsch Lungenkrankheiten Und T | Verfahren zur herstellung einer kombinationsvakzine mit intensivierter wirkung |
US5091188A (en) | 1990-04-26 | 1992-02-25 | Haynes Duncan H | Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs |
FR2662942B1 (fr) * | 1990-06-06 | 1992-09-18 | Neway Tsehay | Medicament immunostimulant a base de glycopeptidolipides polaires de mycobacterium chelonae. |
US5178882A (en) | 1990-06-22 | 1993-01-12 | The Regents Of The University Of California | Viral decoy vaccine |
NZ286242A (en) | 1991-03-26 | 1997-11-24 | Csl Ltd | Use of veterinary implant as a single dose vaccination system: rupturable polymer film coating around core of active agent and water soluble excipient |
US5206219A (en) | 1991-11-25 | 1993-04-27 | Applied Analytical Industries, Inc. | Oral compositions of proteinaceous medicaments |
BR9306707A (pt) * | 1992-07-06 | 1998-12-08 | Harvard College | Mutantes de deleção como vacinas contra cólera |
WO1994017813A1 (en) | 1993-02-08 | 1994-08-18 | Paravax, Inc. | Defective sindbis virus vectors that express toxoplasma gondii p30 antigens |
NZ273865A (en) * | 1993-09-20 | 1997-12-19 | Anadis Ltd | Obtaining high purity ig from antibody rich colostrum and compositions thereof |
US5595761A (en) | 1994-01-27 | 1997-01-21 | The Board Of Regents Of The University Of Oklahoma | Particulate support matrix for making a rapidly dissolving tablet |
US5576014A (en) | 1994-01-31 | 1996-11-19 | Yamanouchi Pharmaceutical Co., Ltd | Intrabuccally dissolving compressed moldings and production process thereof |
US5635210A (en) * | 1994-02-03 | 1997-06-03 | The Board Of Regents Of The University Of Oklahoma | Method of making a rapidly dissolving tablet |
IL120202A (en) * | 1996-03-07 | 2001-03-19 | Akzo Nobel Nv | Container with freeze-dried vaccine components |
US5912014A (en) | 1996-03-15 | 1999-06-15 | Unigene Laboratories, Inc. | Oral salmon calcitonin pharmaceutical products |
CA2285184A1 (en) * | 1996-04-22 | 1997-10-30 | Peter R. Rothschild | Stabilized antihepatitis-b vaccine tablets |
HRP970493A2 (en) | 1996-09-23 | 1998-08-31 | Wienman E. Phlips | Oral delayed immediate release medical formulation and method for preparing the same |
AU4133397A (en) * | 1996-10-28 | 1998-05-22 | Pfizer Inc. | Oral vaccines for young animals with an enteric coating |
US6150340A (en) * | 1997-02-07 | 2000-11-21 | Smithkline Beecham Corporation | RNA-dependent amidotransferase from Staphylococcus aureus |
JPH1121122A (ja) * | 1997-07-03 | 1999-01-26 | Akou Kaisui Kk | 水溶解性に優れた塩錠剤 |
DE19741114C2 (de) | 1997-09-12 | 2002-10-24 | Riemser Arzneimittel Ag | Feuchtigkeitsstabile und magensaftresistente Arzneiform für Fische |
CU22700A1 (es) | 1997-09-29 | 2001-07-31 | Ct Ingenieria Genetica Biotech | Formulación farmacéutica anti-viral que contiene un péptido de la proteína factor anti-lps de limulus y su uso |
GB9722682D0 (en) | 1997-10-27 | 1997-12-24 | Scherer Ltd R P | Pharmaceutical products |
GB9801870D0 (en) | 1998-01-28 | 1998-03-25 | Raby Limited | Vaccine composition |
WO2000048662A1 (en) * | 1999-02-16 | 2000-08-24 | Prismedical Corporation | Single dose delivery device |
-
2000
- 2000-08-21 ES ES00955789.3T patent/ES2605109T3/es not_active Expired - Lifetime
- 2000-08-21 CA CA002382652A patent/CA2382652A1/en not_active Abandoned
- 2000-08-21 TR TR2002/00477T patent/TR200200477T2/xx unknown
- 2000-08-21 IL IL14824700A patent/IL148247A0/xx unknown
- 2000-08-21 PL PL00364983A patent/PL364983A1/xx not_active Application Discontinuation
- 2000-08-21 AU AU67934/00A patent/AU779403B2/en not_active Ceased
- 2000-08-21 US US09/642,913 patent/US6541001B1/en not_active Expired - Lifetime
- 2000-08-21 DK DK00955789.3T patent/DK1212045T3/en active
- 2000-08-21 LT LTEP00955789.3T patent/LT1212045T/lt unknown
- 2000-08-21 WO PCT/US2000/022929 patent/WO2001013896A1/en active IP Right Grant
- 2000-08-21 BR BRPI0014142A patent/BRPI0014142B8/pt not_active IP Right Cessation
- 2000-08-21 CN CNB008144478A patent/CN100406004C/zh not_active Expired - Lifetime
- 2000-08-21 MX MXPA02001891A patent/MXPA02001891A/es active IP Right Grant
- 2000-08-21 PT PT955789T patent/PT1212045T/pt unknown
- 2000-08-21 JP JP2001518034A patent/JP5209160B2/ja not_active Expired - Fee Related
- 2000-08-21 EP EP00955789.3A patent/EP1212045B1/en not_active Expired - Lifetime
- 2000-08-21 HU HU0202537A patent/HUP0202537A3/hu unknown
- 2000-08-21 RU RU2002107313/15A patent/RU2277905C2/ru active
-
2002
- 2002-02-19 IL IL148247A patent/IL148247A/en active IP Right Grant
- 2002-03-05 ZA ZA200201816A patent/ZA200201816B/xx unknown
- 2002-11-25 HK HK02108510.2A patent/HK1047696A1/zh unknown
-
2016
- 2016-11-15 CY CY20161101172T patent/CY1118521T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
JP2003507414A (ja) | 2003-02-25 |
BRPI0014142B8 (pt) | 2021-05-25 |
CA2382652A1 (en) | 2001-03-01 |
PT1212045T (pt) | 2016-11-22 |
MXPA02001891A (es) | 2003-07-21 |
CN1379663A (zh) | 2002-11-13 |
ZA200201816B (en) | 2003-05-28 |
BRPI0014142B1 (pt) | 2016-09-27 |
AU6793400A (en) | 2001-03-19 |
HUP0202537A3 (en) | 2004-05-28 |
EP1212045A1 (en) | 2002-06-12 |
IL148247A (en) | 2014-01-30 |
JP5209160B2 (ja) | 2013-06-12 |
LT1212045T (lt) | 2016-12-12 |
CN100406004C (zh) | 2008-07-30 |
DK1212045T3 (en) | 2016-11-28 |
AU779403B2 (en) | 2005-01-20 |
WO2001013896A1 (en) | 2001-03-01 |
PL364983A1 (en) | 2004-12-27 |
ES2605109T3 (es) | 2017-03-13 |
IL148247A0 (en) | 2002-09-12 |
US6541001B1 (en) | 2003-04-01 |
RU2277905C2 (ru) | 2006-06-20 |
EP1212045B1 (en) | 2016-08-17 |
CY1118521T1 (el) | 2017-07-12 |
EP1212045A4 (en) | 2008-02-20 |
BR0014142A (pt) | 2002-07-02 |
TR200200477T2 (tr) | 2002-06-21 |
HK1047696A1 (zh) | 2003-03-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0202537A2 (hu) | Vakcinakészítmény és eljárás annak alkalmazására | |
MY129263A (en) | Vaccine composition | |
SV2004001556A (es) | Preparaciones acidas de insulina con establidad mejorada | |
HUP0303720A2 (hu) | Egy immunstimuláns oligonukleotidot és egy tokolt tartalmazó adjuvánskészítmény | |
HUP0000839A2 (hu) | Ciklosporint és egy anionos felületaktív szert tartalmazó szilárd gyógyszerkészítmények és eljárás ezek előállítására | |
ES2110377T1 (es) | Formulacion galenica de fenofibrato y aplicacion de la misma. | |
DK1126828T3 (da) | Oral indgivelse af adenosin-analoger | |
BR9808933A (pt) | Composição sob forma de microcápsulas ou de implantes, processo de preparação de uma substância hidrossolúvel, substância ativa, acetato de triptorelina, acetato de lanreotìdeo, ou acetato de octreotìdeo, e rna de filamento duplo | |
DK1187629T3 (da) | Adjuvanssammensætning omfattende saponin og et immunostimulerende oligonucleotid | |
ATE270544T1 (de) | Halbfeste arzneizubereitung enthaltend isotretinoin | |
BG66093B1 (bg) | Състави с контролирано освобождаване, съдържащи нимесулид | |
NO20100302L (no) | Sammensetninger som inneholder organiske forbindelser | |
ATE329897T1 (de) | Verbindungen und zusammensetzungen zur verabreichung aktiven substanzen | |
ATE554750T1 (de) | Hydrophobe pharmazeutische wirkstoffe enthaltende zubereitungen | |
BR9915988A (pt) | Vacina para peptidase c5a estreptocócica | |
TR200001892T2 (tr) | Monomer cinsi ensülin analogları ve bunların kullanımı. | |
ATE146360T1 (de) | Gonadotropin enthaltende gefriergetrocknete troepfen | |
HUP0401606A2 (hu) | West Nile vakcina | |
ATE224717T1 (de) | Oral anzuwendende arzneizubereitungen enthaltend eine benzhydrylpiperazine und eine zyklodextrin | |
CY1109661T1 (el) | 5-cnac ως παραγοντας για χορηγηση απο το στομα τμηματων παραθορμονης | |
ATE270707T1 (de) | Entepneumovirus und entsprechendes impfstoff | |
HUP0301349A2 (hu) | IL-11-tartalmú készítmények | |
HUP0002683A2 (hu) | Terápiás anyagok sejtekhez való eljuttatásának fokozására szolgáló készítmények és módszerek | |
CA2335551A1 (en) | Thyroid hormone analogues and methods for their preparation | |
DK1024824T3 (da) | Dispergerende vaccinesammensætning i fast form til oral indgivelse |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD9A | Lapse of provisional protection due to non-payment of fees |